Aclarion, Inc. (NASDAQ:ACONW) Short Interest Down 42.8% in July

Aclarion, Inc. (NASDAQ:ACONW) was the recipient of a large decrease in short interest during the month of July. As of July 15th, there was short interest totaling 2,622 shares, a decrease of 42.8% from the June 30th total of 4,580 shares. Based on an average daily trading volume, of 5,099 shares, the short-interest ratio is presently 0.5 days.

Aclarion Stock Up 5.6%

NASDAQ ACONW opened at $0.02 on Thursday. The firm’s 50-day simple moving average is $0.03 and its two-hundred day simple moving average is $0.03. Aclarion has a 52 week low of $0.02 and a 52 week high of $0.23.

About Aclarion

Aclarion, Inc, a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc and changed its name to Aclarion, Inc in December 2021.